Douglas Sheafor
Psychiatry · Topeka, KSNPI 1407830037
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 25.6% of the total.
Across 124 payments — averaging $13.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$427
- Otsuka America Pharmaceutical, Inc.$269
- Sunovion Pharmaceuticals Inc.$148
- Lundbeck LLC$134
- Takeda Pharmaceuticals U.S.A., Inc.$120
- Jazz Pharmaceuticals Inc.$87
- plus $484 from 13 others
What the payments were for
- Food & beverage$1,669100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,669 in reported general payments places this provider in the 75th percentile of 259 psychiatry providers in Kansas.
Other psychiatry in Topeka
- Ethan BickelhauptTopeka$12K
- David WichmanManhattan$613K
- Kevin MaysLeawood$548K
- Sheldon PreskornWichita$498K
- James OwensSalina$433K
- Sasha HamdaniOverland Park$104K
- Christine GlennKansas City$58K
- Heidi OgdenWichita$55K
- Mark RomereimHays$41K
- Patrick StangGreat Bend$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.